You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 26, 2024

APOTEX INC Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for APOTEX INC, and what generic and branded alternatives to APOTEX INC drugs are available?

APOTEX INC has one hundred and five approved drugs.

There are thirteen tentative approvals on APOTEX INC drugs.

Drugs and US Patents for APOTEX INC

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apotex Inc OLANZAPINE olanzapine TABLET, ORALLY DISINTEGRATING;ORAL 091265-002 Oct 24, 2011 AB RX No No ⤷  Subscribe ⤷  Subscribe
Apotex Inc MIRTAZAPINE mirtazapine TABLET;ORAL 077666-003 Aug 22, 2007 AB RX No No ⤷  Subscribe ⤷  Subscribe
Apotex Inc CILOSTAZOL cilostazol TABLET;ORAL 077030-001 Dec 10, 2004 AB RX No No ⤷  Subscribe ⤷  Subscribe
Apotex Inc RIVASTIGMINE TARTRATE rivastigmine tartrate CAPSULE;ORAL 091072-002 May 16, 2013 DISCN No No ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.